-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QXCaB8ZCqvg/8X9Jt5lvY98mjFM1uoeK2CNxE7pXhQ3XUHHMqj4Pv/c6E7AKGgEJ f+QUfdKpcDEX9Ptnsi+PeQ== 0001123292-07-000550.txt : 20070619 0001123292-07-000550.hdr.sgml : 20070619 20070619173328 ACCESSION NUMBER: 0001123292-07-000550 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070618 FILED AS OF DATE: 20070619 DATE AS OF CHANGE: 20070619 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mazel Sidney CENTRAL INDEX KEY: 0001365774 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19131 FILM NUMBER: 07929598 BUSINESS ADDRESS: BUSINESS PHONE: 301-398-0000 MAIL ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEDIMMUNE INC /DE CENTRAL INDEX KEY: 0000873591 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 521555759 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 BUSINESS PHONE: 301-398-0000 MAIL ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2007-06-18 1 0000873591 MEDIMMUNE INC /DE MEDI 0001365774 Mazel Sidney ONE MEDIMMUNE WAY GAITHERSBURG MD 20878 0 1 0 0 SVP, Product Planning Stock Option (right to buy) 29.60 2007-06-18 4 D 0 60000 0 D 2016-06-11 Common Stock 60000 0 D Stock Option (right to buy) 31.25 2007-06-18 4 D 0 50000 0 D 2017-02-14 Common Stock 50000 0 D This option, which provided for vesting with respect to 1/4 of the shares on 06/12/2007 and with respect to the remaining shares in equal quarterly installments thereafter, was cancelled pursuant to the merger agreement between the issuer and AstraZeneca PLC in exchange for a cash payment of $28.40 per share, representing the difference between the exercise price of the option and $58.00 per share. This option, which provided for vesting in equal quarterly installments beginning 5/15/2007, was cancelled in the merger in exchange for a cash payment of $26.75 per share, representing the difference between the exercise price of the option and $58.00 per share. /s/ William C. Bertrand, Jr., Attorney-in-Fact 2007-06-19 -----END PRIVACY-ENHANCED MESSAGE-----